corresp
Fulbright
& Jaworski L.L.P.
A Registered Limited Liability Partnership
Fulbright Tower
1301 McKinney, Suite 5100
Houston, Texas 77010-3095
www.fulbright.com
telephone: (713) 651-5151
January 7, 2008
BY FACSIMILE (202) 772-9368
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
|
|
|
Re:
|
|
Quanex Corporation |
|
|
Preliminary Proxy Statement on Schedule 14A |
|
|
Filed on: December 20, 2007 |
|
|
File No. 001-05725 |
Ladies and Gentlemen:
By letter dated January 2, 2008, Quanex Corporation (the Company) received the Staffs
comments relating to the above listed filing of the Company (the Comment Letter). The Company
intends to file a response to the Comment Letter later this week with the Securities and Exchange
Commission (SEC) specifically addressing the comments. In the meantime, in response to a request
made by Era Anagnosti of the Staff following a phone conference between Ms. Anagnosti and Martin
Doublesin of our firm on Friday January 4, 2008, we would like to present the Companys plans
regarding the proxy statement and the filing of a Form 10 by the Companys subsidiary.
As noted in the Companys proxy statement, immediately prior to the merger discussed in the
proxy statement, the Company plans to spin off to its stockholders the securities of a subsidiary
of the Company containing the Companys building products business. While the Company for tax
reasons intends to spin-off a limited liability company containing the building products business,
that limited liability company will, immediately following the spin-off, merge into Quanex Building
Products Corporation (QBPC), a wholly-owned corporate subsidiary of the limited liability
company. Quanexs stockholders will therefore end up with publicly-traded shares of QBPC. As
discussed with and confirmed by Ms. Anagnosti last week, QBPC will be the entity that will file a
Form 10 with the SEC.
In order to be able to comply with the requirements of Schedule 14A regarding including
financial and other information regarding the spin-off in the proxy statement, Quanex intends to
incorporate by reference the Form 10 to be filed by QBPC. In accordance with Note D to Schedule
14A, the Company intends to note in several places in the proxy statement that QBPCs Form 10 is
being incorporated by reference, including in the sections titled Summary,
Austin Beijing Dallas Denver Dubai Hong Kong Houston London Los Angeles Minneapolis
Munich New York Riyadh San Antonio St. Louis Washington DC
Securities and Exchange Commission
January 7, 2008
Page 2
Questions and Answers About the Special Meeting and Voting, The Spin-Off, and Where You
Can Find More Information. The Company will also undertake in the proxy statement to provide,
without charge, to each person to whom a proxy statement is delivered, upon written or oral request
of such person and by first class mail or other equally prompt means within one business day of
receipt of such request, a copy of the Form 10 that has been incorporated by reference in the proxy
statement, and the address and telephone numbers to which such a request is to be directed.
We note that the Company is a registrant that meets the requirements of Form S-3. We believe
that the Company, as a Form S-3 registrant, should be able to incorporate by reference the
previously-filed Form 10 filing of its wholly-owned subsidiary. Because QBPC is a wholly-owned
subsidiary of the Company, the Company will have adequate access to copies of QBPCs Form 10 to be
able to distribute them to the Companys stockholders upon request. The Form 10 will also be
available to the Companys stockholders through the SECs and the Companys websites.
We ask for the Staffs concurrence with the Companys approach described above regarding
incorporation by reference of QBPCs Form 10. If any member of the Staff has any questions
concerning these matters or needs additional information or clarification, he or she should contact
the undersigned at (713) 651-5128 or Michael W. Conlon of this firm at (713) 651-5427.
Very truly yours,
/s/ Martin F. Doublesin
Martin F. Doublesin
|
|
|
cc:
|
|
Kevin P. Delaney (Quanex Corporation) |
|
|
Michael W. Conlon (Firm) |